Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 02, 2021

SELL
$148.08 - $206.57 $1 Million - $1.4 Million
-6,763 Closed
0 $0
Q3 2020

Oct 23, 2020

SELL
$122.51 - $158.27 $1,960 - $2,532
-16 Reduced 0.24%
6,763 $998,000
Q2 2020

Jul 21, 2020

BUY
$94.33 - $140.48 $15,187 - $22,617
161 Added 2.43%
6,779 $838,000
Q1 2020

Apr 21, 2020

BUY
$84.96 - $109.14 $562,265 - $722,288
6,618 New
6,618 $639,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.6B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Cordatus Wealth Management LLC Portfolio

Follow Cordatus Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordatus Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cordatus Wealth Management LLC with notifications on news.